Daniel Duncan

Daniel Duncan is an experienced medical professional specializing in pathology and molecular genetics, with a robust career spanning over a decade. Notable roles include Senior Medical Director and Medical Director at GRAIL from July 2021 to March 2023, and Senior Pathologist and Associate Medical Director at Foundation Medicine from January 2018 to August 2021. Additionally, Daniel held the position of Director of Translational Next Generation Sequencing and Medical Director at Cancer Genetics, Inc. from July 2016 to August 2021. Daniel advanced clinical expertise through a fellowship in Molecular Genetics and Hematopathology at the University of North Carolina at Chapel Hill, following completion of residency training in pathology. Daniel earned a Doctor of Medicine degree from the Medical University of South Carolina, furthering education through the University of North Carolina at Chapel Hill.